As of 5 Nov 2026, Venomics AI has raised $2.7M across 1 verified round on record; latest: US$2.7 million pre-seed round led by South Park Commons and Speciale Invest, announced 5 Nov 2026.
A biotechnology startup from the Indian Institute of Science
venomics.aiLinkedInBengaluru, IndiaBiotech
3 sources · checked 1 time, last 2h ago
Sources agree on the round, amount, stage, and syndicate. The announcement date is taken from the dated BioSpectrum article.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed | $2.7M | 2026-11-05 | South Park Commons, Speciale Invest | 3 outlets. #56 in Trending |
3 sources · checked 1 time, last 2h ago [ VERIFIED ] read against 3 sources Sources agree on the round, amount, stage, and syndicate. The announcement date is taken from the dated BioSpectrum article. | ||||
Venomics AI builds an AI-powered venom-to-therapeutics discovery platform that decodes animal venoms, screens their molecules, and advances promising candidates toward medicines.
Venomics AI matters because venom contains a vast library of evolution-optimized peptides, and the company combines a proprietary Venom Atlas with AI and laboratory screening to look for drug candidates. Its $2.7M pre-seed round is intended to expand the dataset, add AI and lab-screening capacity, and support hiring across venom biology, computational science, and drug discovery.
Checked against 6 sources today
Also named as backers in company research: ARTPARK, NVIDIA